This content is machine translated Pompe's disease Further development of enzyme replacement therapy provides new treatment option New data from the open-label, long-term extension of the randomized, double-blind, Phase 3 COMET study show that people with late-stage Pompe disease (LOPD) maintained improvements in respiratory function and mobility…
View Post 3 min This content is machine translated Malignant melanoma with BRAFV600 mutation More melanomas in advanced stages – pandemic-related late effects? Uptake of skin cancer screening plummeted in the corona pandemic. Therefore, early detection and treatment of skin cancer now deserves special attention. In patients with advanced melanoma and a BRAFV600…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis Secukinumab as a treatment option in pediatric patients – an update. Children and adolescents affected by psoriasis and/or psoriatic arthritis often suffer a great deal. Particularly in cases of severe symptoms, the quality of life of those affected and their families…
View Post 2 min This content is machine translated Pastoral care in health care Professional association founded In order to actively shape the future of the chaplaincy profession in healthcare, the associations of Catholic and Protestant chaplaincy in German-speaking Switzerland are joining forces to form the professional…
View Post 2 min This content is machine translated Multiple sclerosis Glatiramer acetate now also approved for use in the breastfeeding period Glatiramer acetate 20 mg/ml and 40 mg/ml, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has updated its SmPC. The product is now approved for…
View Post 2 min This content is machine translated Breast Cancer Regulatory extension for anti-PD-1 therapy with pembrolizumab Swissmedic has granted a further marketing authorization for anti-PD-1 therapy with pembrolizumab. This can now be approved in combination with chemotherapy in Switzerland for the treatment of patients with locally…
View Post 3 min This content is machine translated Conference on Retroviruses and Opportunistic Infections (CROI 2022) Five-year data of single-tablet regimen B/F/TAF published. At the 29th CROI, Gilead Sciences presented five-year data from two Phase 3 studies (Study 1489 and Study 1490) that evaluated use in untreated individuals living with HIV. The results…
View Post 6 min This content is machine translated Now cash-registered and available in Switzerland Highly effective herpes zoster vaccine approved The Federal Office of Public Health (FOPH) and the Swiss Federal Commission for Immunization Questions (EKIF) recommend vaccination against herpes zoster with the new recombinant inactivated vaccine consisting of the…
View Post 3 min This content is machine translated Plaque psoriasis 5-Year Data on Ixekizumab: Patients Benefit Over the Long Term Continuous therapy with the anti-IL17 antibody ixekizumab has shown sustained long-term improvements in itch, skin pain, and health-related quality of life in patients with moderate to severe plaque psoriasis. Patients…
View Post 3 min This content is machine translated Chronic wounds Cold plasma jet accelerates wound healing Chronic wounds are often associated with high morbidity and significant impairment in patients’ daily lives. In a comparative clinical study, treatment with an innovative cold plasma jet procedure resulted in…
View Post 4 min This content is machine translated Metastatic urothelial carcinoma of the urinary bladder Therapy in transition Despite the pandemic, this year’s Swiss Oncology and Hematology Congress (SOHC) was held face-to-face – with more than 1300 participants. Metastatic urothelial carcinoma of the urinary bladder was also a…
